Home Watchlists Portfolios Indices Forex Futures Crypto Comparisons Alerts Screeners Scans Settings

Vistagen Therapeutics (NASDAQ:VTGN) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS



  • Source: Trent Times - - Read: 0

    Summary:

     

    Vistagen Therapeutics (NASDAQ:VTGN) announced its quarterly earnings data on Thursday. The company reported ($0.13) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.01, Fidelity Earnings reports.

    Shares of NASDAQ VTGN opened at $1.08 on Friday. The company has a market cap of $46.20 million, a PE ratio of -1.20 and a beta of -0.29. The company has a quick ratio of 2.65, a current ratio of 2.65 and a debt-to-equity ratio of 2.44. Vistagen Therapeutics has a 52-week low of $0.38 and a 52-week high of $2.06. The firm’s 50-day moving average price is $1.15 and its 200-day moving average price is $0.83.

    Several brokerages recently commented on VTGN. ValuEngine raised shares of Vistagen Therapeutics from a “hold” rating to a “buy” rating in a research r ...

     

     

    Read Full News: https://trentdailytimes.com/2019/11/10/vistagen-therapeutics-nasdaqvtgn-announces-quarterly-earnings-results-beats-expectations-by-0-01-eps.html


Log in to reply